Annalisa Jenkins CV

Annalisa Jenkins, Head of Global Research and Development, Merch Serono

Annalisa, Jenkins;, Head, of, Global, Research, and, Development;, Merch, Serono

FDA

• Browser built in viewer
• PDF Viewer
• Universal Document Viewer
• Google Docs View
• Google Drive View
• Download Document [pdf]
Not Your Device? Search For Manuals / Datasheets:



File Info : application/pdf, 1 Pages, 149.37KB

Document Document

,Merck Serano
I

I II
',MERCK I I

Annalisa Jenkins Head of Global Research and Development
Dr. Annalisa Jenkins, MBBS, MRCP, is Executive Vice President, Head of Global Research and Development for Merck Serono (EMD Serono is the US subsidiary of Merck, Darmstadt, Germany). In addition, she leads Global Medical Affairs and Quality. Dr. Jenkins is a member of the Pharmaceutical Executive Committee. She joined the company in 2011, previously serving as Head of Global Development and Medical.
Prior to joining Merck Serono, Dr. Jenkins was Senior Vice President, Global Medical Affairs at Bristol-Myers Squibb (BMS). She started with BMS in 1997 in the UK. In 2000, she moved to Australia to serve as Executive Medical Director for Australia and New Zealand, subsequently leading the Medical Division across Asia Pacific and Latin America.
In 2002, Dr. Jenkins moved to BMS's major R&D site in Princeton, New Jersey, to oversee the company's International Medical Division. After three years in this role, she was appointed Chief Medical Officer (CMO) for Europe, Middle East and Africa, subsequently taking on the position of Senior Vice President and CMO responsible for the Americas and the Development Teams. During her tenure at BMS she made significant contributions to the globalization of Medical Affairs, the progression of a number of the key pipeline programs and the execution of a number of strategic transactions.
Dr. Jenkins began her career as a Medical Officer with the British Royal Navy, and served with the Minesweeper Squadron during the Gulf conflict, rising to the rank of Surgeon Lieutenant Commander. She graduated in Medicine from St. Bartholomew's Hospital London and trained in Cardiovascular Medicine in the UK National Health Service.
Dr. Jenkins is Chair of the Board of Transcelerate Biopharma Inc. In addition, she serves on the Boards of Directors for the Healthcare Businesswomen's Association European Chapter; the Concert Artists Guild New York; and the corporate advisory board of the Center for Talent Innovation. She is also a member of the Scientific Leadership Advisory Council at PhRMA.
Dr. Jenkins was named the Healthcare Businesswomen's Association Woman of the Year in 2014, a prestigious award that honors exceptional leaders and role models in the healthcare industry.
Annalisa Jenkins - Merck KGaA - Frankfurter Str. 250 - 64293 Darmstadt - +49 151 1454 7200